Lynparza 150 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FY8QK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,568
Award facts
- Contract value 100% obligated
- $10,567.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a Delivery Order valued at $10,567.60 by the Defense Logistics Agency (DLA) for the supply of LYNPARZA 150 mg tablets (120-count units). The contract is a firm fixed-price, non-set-aside award with a completion date of August 21, 2025, and was issued on July 31, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical commodities to military healthcare systems globally.
The DLA Medical Supply Chain manages pharmaceutical procurement to support military and veteran healthcare operations. LYNPARZA (olaparib) is a prescription oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products AmerisourceBergen provides through its federal contracts. The competitive award demonstrates the company's continued capability to fulfill federal medical supply requirements and aligns with its established role as a critical pharmaceutical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FY8QK?
SPE2DB25FY8QK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FY8QK worth?
The government has obligated $10,568 on SPE2DB25FY8QK.
Is contract SPE2DB25FY8QK an order under another contract?
Yes. SPE2DB25FY8QK is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8QK competed?
The extent of competition for SPE2DB25FY8QK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award